Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1798]
News [2689]
Articles [196]
Editorials [1]
Conferences [135]
elearning [13]
PLEIADES: Daratumumab combinations for multiple myeloma
Dr Ajai Chari - Mount Sinai, New York City, USA
PLEIADES: Daratumumab combinations for multiple myeloma ( Dr Ajai Chari - Mount Sinai, New York City, USA )
25 Sep 2019
Ruxolitinib, lenalidomide and methylprednisolone for relapsed/refractory...
Dr James Berenson - Oncotherapeutics, West Hollywood, USA
Ruxolitinib, lenalidomide and methylprednisolone for relapsed/refractory multiple myeloma ( Dr James Berenson - Oncotherapeutics, West Hollywood, USA )
25 Sep 2019
Treatment options for high risk relapsed/refractory multiple myeloma
Dr James Berenson - Oncotherapeutics, West Hollywood, USA
Treatment options for high risk relapsed/refractory multiple myeloma ( Dr James Berenson - Oncotherapeutics, West Hollywood, USA )
25 Sep 2019
BCMA: A new biomarker for multiple myeloma
Dr James Berenson - Oncotherapeutics, West Hollywood, USA
BCMA: A new biomarker for multiple myeloma ( Dr James Berenson - Oncotherapeutics, West Hollywood, USA )
25 Sep 2019
ICARIA: Isatuximab, pomalidomide and dexamethasone in relapsed/refractory...
Prof Simon Harrison - Peter MacCallum Cancer Centre, Melbourne, Australia
ICARIA: Isatuximab, pomalidomide and dexamethasone in relapsed/refractory multiple myeloma ( Prof Simon Harrison - Peter MacCallum Cancer Centre, Melbourne, Australia )
25 Sep 2019
BELLINI: Venetoclax or placebo with bortezomib and dexamethasone for relapsed...
Prof Simon Harrison - Peter MacCallum Cancer Centre, Melbourne, Australia
BELLINI: Venetoclax or placebo with bortezomib and dexamethasone for relapsed/refractory multiple myeloma ( Prof Simon Harrison - Peter MacCallum Cancer Centre, Melbourne, Australia )
25 Sep 2019
Transitioning from bortezomib to ixazomib in patients with multiple myeloma
Dr Habte Yimer - Texas Oncology, Tyler, USA
Transitioning from bortezomib to ixazomib in patients with multiple myeloma ( Dr Habte Yimer - Texas Oncology, Tyler, USA )
23 Sep 2019
Advances in the treatment of peritoneal metastases in gastric cancer
Dr Geraldo Alves - Hospital Santa Rosa, Brasil
Advances in the treatment of peritoneal metastases in gastric cancer ( Dr Geraldo Alves - Hospital Santa Rosa, Brasil )
7 Aug 2019
New standard of care for lung cancer patients with EGFR mutations
Dr Gelenis Domingo - Memorial Healthcare System, Hollywood, FL, USA
New standard of care for lung cancer patients with EGFR mutations ( Dr Gelenis Domingo - Memorial Healthcare System, Hollywood, FL, USA )
26 Jul 2019
Recent advances in smouldering and relapsed or refractory multiple myeloma
Dr Jose Sandoval - Moffitt Cancer Center, Tampa, USA
Recent advances in smouldering and relapsed or refractory multiple myeloma ( Dr Jose Sandoval - Moffitt Cancer Center, Tampa, USA )
26 Jul 2019
Latest updates in HER2-positive metastatic breast cancer: The NALA and SOPHIA...
Dr Connie Guaqueta - Memorial Cancer Institute, Miami, USA
Latest updates in HER2-positive metastatic breast cancer: The NALA and SOPHIA trials ( Dr Connie Guaqueta - Memorial Cancer Institute, Miami, USA )
26 Jul 2019
Providing quality patient care and service using the Oncology Care Model
Dr Vedner Guerrier - Memorial Healthcare System, Hollywood, FL, USA
Providing quality patient care and service using the Oncology Care Model ( Dr Vedner Guerrier - Memorial Healthcare System, Hollywood, FL, USA )
26 Jul 2019

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation